{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:42:55Z","timestamp":1762033375067},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"name":"Intramural Research Program of the National Cancer Institute, NCI."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1002\/ijc.30456","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T12:09:29Z","timestamp":1475842169000},"page":"718-725","source":"Crossref","is-referenced-by-count":17,"title":["Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have \u2265CIN2"],"prefix":"10.1002","volume":"140","author":[{"given":"Mark","family":"Schiffman","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Zuna","sequence":"additional","affiliation":[{"name":"Oklahoma University Health Sciences Center; Oklahoma City OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Terence Dunn","sequence":"additional","affiliation":[{"name":"Oklahoma State Department of Health; Oklahoma City OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Walker","sequence":"additional","affiliation":[{"name":"Oklahoma State Department of Health; Oklahoma City OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[{"name":"Tulsa Cancer Institute; Tulsa OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorie","family":"Hyun","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Rydzak","sequence":"additional","affiliation":[{"name":"Information Management Services; Calverton MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hormuzd A.","family":"Katki","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Bethesda MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"10.1002\/ijc.30456-BIB0001|ijc30456-cit-0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens-Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1002\/ijc.30456-BIB0002|ijc30456-cit-0002","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer (Review)","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/ijc.30456-BIB0003|ijc30456-cit-0003","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","article-title":"Authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012. Comprehensive control of human papillomavirus infections and related diseases","volume":"31(Suppl7)","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1002\/ijc.30456-BIB0004|ijc30456-cit-0004","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening (Review)","volume":"76(Suppl1)","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1002\/ijc.30456-BIB0005|ijc30456-cit-0005","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/ijc.30456-BIB0006|ijc30456-cit-0006","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30456-BIB0007|ijc30456-cit-0007","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30456-BIB0008|ijc30456-cit-0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2006.01.091","article-title":"Colposcopy at a crossroads","volume":"195","author":"Jeronimo","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/ijc.30456-BIB0009|ijc30456-cit-0009","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ygyno.2012.10.017","article-title":"Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany","volume":"128","author":"Petry","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30456-BIB0010|ijc30456-cit-0010","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/ijc.30456-BIB0011|ijc30456-cit-0011","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30456-BIB0012|ijc30456-cit-0012","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1002\/ijc.30456-BIB0013|ijc30456-cit-0013","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1002\/ijc.30456-BIB0014|ijc30456-cit-0014","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results","volume":"53","author":"Schiffman","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1002\/ijc.30456-BIB0015|ijc30456-cit-0015","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/ijc.30456-BIB0016|ijc30456-cit-0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cncr.10317","article-title":"Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom","volume":"96","author":"Scott","year":"2002","journal-title":"Cancer"},{"key":"10.1002\/ijc.30456-BIB0017|ijc30456-cit-0017","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":"Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants","volume":"125","author":"Wentzensen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30456-BIB0018|ijc30456-cit-0018","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2014.55.9948","article-title":"Multiple biopsies and detection of cervical cancer precursors at colposcopy","volume":"33","author":"Wentzensen","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.30456-BIB0019|ijc30456-cit-0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-6413-1-4","article-title":"Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project","volume":"1","author":"Nayar","year":"2004","journal-title":"Cytojournal"},{"key":"10.1002\/ijc.30456-BIB0020|ijc30456-cit-0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0142(19971225)81:6<337::AID-CNCR7>3.0.CO;2-I","article-title":"The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study","volume":"81","author":"Patten","year":"1997","journal-title":"Cancer"},{"key":"10.1002\/ijc.30456-BIB0021|ijc30456-cit-0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"key":"10.1002\/ijc.30456-BIB0022|ijc30456-cit-0022","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/ijc.30456-BIB0023|ijc30456-cit-0023","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ijc.29143","article-title":"Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection","volume":"136","author":"Gage","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30456-BIB0024|ijc30456-cit-0024","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1002\/ijc.30456-BIB0025|ijc30456-cit-0025","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30456","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ijc.30456\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T20:32:11Z","timestamp":1625171531000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.30456"}},"subtitle":["Cervical screening using HPV typing and automated cytology"],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.30456","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,17]]}}}